Follow
Shamiza Hussein
Shamiza Hussein
Unknown affiliation
Verified email at novartis.com
Title
Cited by
Cited by
Year
Global mapping of the yeast genetic interaction network
AHY Tong, G Lesage, GD Bader, H Ding, H Xu, X Xin, J Young, GF Berriz, ...
science 303 (5659), 808-813, 2004
24722004
Analysis of β-1, 3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin
G Lesage, AM Sdicu, P Ménard, J Shapiro, S Hussein, H Bussey
Genetics 167 (1), 35-49, 2004
2042004
An interactional network of genes involved in chitin synthesis in Saccharomyces cerevisiae
G Lesage, J Shapiro, CA Specht, AM Sdicu, P Ménard, S Hussein, ...
BMC genetics 6, 1-16, 2005
1312005
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America
KA Papp, M Gooderham, J Beecker, CW Lynde, I Delorme, I Dei-Cas, ...
BMC dermatology 19, 1-7, 2019
72019
Secukinumab treated patients in the PURE registry (patients with moderate to severe chronic plaque psoriasis in Latin America and Canada): 18 month follow up data
E Mate, K Papp, M Gooderham, C Lynde, R Langley, M Alam, J Beecker, ...
AUSTRALASIAN JOURNAL OF DERMATOLOGY 60, 60-60, 2019
12019
Real-world safety of secukinumab in patients with moderate to severe chronic plaque psoriasis in Latin America and Canada: results from the PURE registry
J Beecker, KA Papp, M Gooderham, V Ho, CW Lynde, M Robern, ...
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 79 (3), AB241-AB241, 2018
12018
Secukinumab-treated patients in the PURE registry (Patients with Moderate to Severe Chronic Plaque Psoriasis in Latin America and Canada): 12-month follow-up data
CW Lynde, KA Papp, M Gooderham, A Alavi, J Beecker, N Wasel, ...
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 79 (3), AB257-AB257, 2018
12018
Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network
RD Inman, D Choquette, M Khraishi, DD Gladman, S Hussein, D Neish, ...
The Journal of Rheumatology 50 (5), 634-640, 2023
2023
Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network
DD Gladman, D Choquette, M Khraishi, RD Inman, S Hussein, D Neish, ...
The Journal of Rheumatology 50 (5), 641-648, 2023
2023
Real-world 12-month Retention on Secukinumab Among Axial Spondyloarthritis Patients Within the Canadian Spondyloarthritis (CanSpA) Research Network
R Inman, D Choquette, M Khraishi, D Gladman, S Hussein, D Neish, ...
JOURNAL OF RHEUMATOLOGY 49 (7), 782-783, 2022
2022
Real-world 12-month Retention on Secukinumab Among Psoriatic Arthritis Patients Within the Canadian Spondyloarthritis (CanSpA) Research Network
D Gladman, D Choquette, M Khraishi, R Inman, S Hussein, D Neish, ...
JOURNAL OF RHEUMATOLOGY 49 (7), 786-787, 2022
2022
Treatment switch from aflibercept to ranibizumab pre-filled syringe in Canadian nAMD and DME patients in a real-world setting: The PRECISE study
S Somani, M Giunta, A Kalevar, R Tuli, L Caron, P Trottier, S Hussein, ...
Investigative Ophthalmology & Visual Science 61 (7), 4203-4203, 2020
2020
DIAGNOSIS OF PSORIATIC ARTHRITIS IN PATIENTS WITH MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS TREATED WITH SECUKINUMAB VS. OTHER TREATMENTS IN THE PURE REGISTRY: INDICATION OF …
K Papp, M Gooderham, J Beecker, C Lynde, I Delorme, I Dei-Cas, ...
ACTA DERMATO-VENEREOLOGICA 98, 48-48, 2018
2018
Impact socioéconomique réel des traitements du psoriasis au Canada et en Amérique latine: le registre PURE
I Delorme, M Gooderham, C Lynde, K Papp, J Beecker, L Albrecht, ...
Annales de Dermatologie et de Vénéréologie 144 (12), S226, 2017
2017
An Interactional Network of Genes Involved in Chitin Synthesis in Saccharomyces Cerevisiae
AM Sdicu, AHY Tong, S Hussein, P Ménard, CA Specht, J Shapiro, ...
BioMed Central, 2005
2005
The system can't perform the operation now. Try again later.
Articles 1–15